MKI67 and neoplasm: Based on the meta-analysis of the available data, we have identified significant predictors of EUR spanning patient-specific (e.g., preoperative Ki-67 levels, eGFR, and NLR), tumor-specific (e.g., tumor stage, lymphovascular invasion, lymph node status), and treatment-specific factors (e.g., positive surgical margins, adjuvant chemotherapy).